These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8342508)

  • 1. Experience with three different third-generation cardioverter-defibrillators in patients with coronary artery disease or cardiomyopathy.
    Porterfield JG; Porterfield LM; Smith BA; Bray L
    Am J Cardiol; 1993 Aug; 72(3):301-4. PubMed ID: 8342508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion rates of induced versus spontaneous ventricular tachycardia by a third generation cardioverter defibrillator. The VENTAK PRx Phase I Investigators.
    Porterfield JG; Porterfield LM; Smith BA; Bray L; Voshage L; Martinez A
    Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 2):170-3. PubMed ID: 7681566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transvenous cardioverter-defibrillators: clinical experience at implantation and follow-up].
    Boriani G; Frabetti L; Capucci A; Galli R; Parlapiano M; Biffi M; Sabbatani P; Spedicato L; Bronzetti G; Pierangeli A
    Cardiologia; 1995 Jun; 40(6):381-9. PubMed ID: 8640850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a tiered therapy defibrillator system used to treat recurrent ventricular arrhythmias refractory to drugs.
    Rankin AC; Zaim S; Powell A; Zaim B; Brooks R; McGovern BA; Garan H; Ruskin JN
    Br Heart J; 1993 Jul; 70(1):61-9. PubMed ID: 8038001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.
    Mitchell JD; Lee R; Garan H; Ruskin JN; Torchiana DF; Vlahakes GJ
    J Thorac Cardiovasc Surg; 1993 Mar; 105(3):453-62; discussion 462-3. PubMed ID: 8445925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest.
    Böcker D; Block M; Isbruch F; Fastenrath C; Castrucci M; Hammel D; Scheld HH; Borggrefe M; Breithardt G
    Br Heart J; 1995 Feb; 73(2):158-63. PubMed ID: 7696026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator.
    Kelly PA; Mann DE; Damle RS; Reiter MJ
    J Am Coll Cardiol; 1994 Jun; 23(7):1531-4. PubMed ID: 8195509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator.
    Wietholt D; Block M; Isbruch F; Böcker D; Borggrefe M; Shenasa M; Breithardt G
    J Am Coll Cardiol; 1993 Mar; 21(4):885-94. PubMed ID: 8185728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with the transvenous Medtronic Pacer Cardioverter Defibrillator (PCD) System.
    Golino A; Pappone C; Panza A; Santomauro M; Iorio D; De Amicis V; Chiariello M; Spampinato N
    Tex Heart Inst J; 1993; 20(4):264-70. PubMed ID: 8298322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.
    J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia].
    Adragão P; Parreira L; Neves J; Morgado F; Abecassis M; Almeida M; Martins D; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1996 Mar; 15(3):195-206, 179, 181. PubMed ID: 8634168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. The Guardian ATP 4210 Multicenter Investigators Group.
    Wood MA; Stambler BS; Damiano RJ; Greenway P; Ellenbogen KA
    J Am Coll Cardiol; 1994 Dec; 24(7):1692-9. PubMed ID: 7963117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias.
    Ricci R; Pignalberi C; Disertori M; Capucci A; Padeletti L; Botto G; Toscano S; Miraglia F; Grammatico A; Santini M
    Eur Heart J; 2002 Sep; 23(18):1471-9. PubMed ID: 12208228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with a new cardioverter defibrillator capable of biphasic waveform pulse and enhanced data storage: results of a prospective multicenter study. European Ventak P2 Investigator Group.
    Neuzner J
    Pacing Clin Electrophysiol; 1994 Jul; 17(7):1243-55. PubMed ID: 7937230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator: Ventritex Cadence.
    Fain ES; Winkle RA
    J Cardiovasc Electrophysiol; 1993 Apr; 4(2):211-23. PubMed ID: 8269293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy.
    Leitch JW; Gillis AM; Wyse DG; Yee R; Klein GJ; Guiraudon G; Sheldon RS; Duff HJ; Kieser TM; Mitchell LB
    J Am Coll Cardiol; 1991 Jul; 18(1):145-51. PubMed ID: 2050917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations and late complications of third-generation automatic cardioverter-defibrillators.
    Nunain SO; Roelke M; Trouton T; Osswald S; Kim YH; Sosa-Suarez G; Brooks DR; McGovern B; Guy M; Torchiana DF
    Circulation; 1995 Apr; 91(8):2204-13. PubMed ID: 7697850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique sensing errors in third-generation implantable cardioverter-defibrillators.
    Callans DJ; Hook BG; Kleiman RB; Mitra RL; Flores BT; Marchlinski FE
    J Am Coll Cardiol; 1993 Oct; 22(4):1135-40. PubMed ID: 8409053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.